Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.

The following is a summary of “Hyponatremia is associated with malignant brain edema after mechanical thrombectomy in acute ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Patients in the endovascular therapy group achieved greater functional outcomes at 90 days. 2. Endovascular therapy resulted in significantly decreased disability and overall mortality. Evidence ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors by enhancing blood flow ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

China: A recent study published in the Journal of Stroke and Cerebrovascular Diseases has highlighted the potential of ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...